Key post hoc analysis of the landmark Steno-2 trial showing that intensified, multifactorial treatment slows progression of diabetic nephropathy and renal function loss in microalbuminuric patients with T2DM
You will leave with a clear treatment plan, including nutritional guidance for a sustainable & healthy diet, as well as a plan for incorporating exercise and movement into your routine
Gaayn-Sidorczuk et al., 2012)
That's a catastrophic error
treatment policy estimand)
According to Rubino, clinical trials are now being planned to assess whether higher doses of GLP-1 drugs can be used in the acute phase to help patients lose weight, followed by lower "maintenance" doses, which come with fewer side effects and can be prescribed on a long-term basis